Multi-Omics Integration and Network Analysis: Uncovering Biological Relationships

Multi-omics integration through network-based methods helps researchers and analysts identify biological relationships that single-omics approaches cannot reveal. This article explains how correlation networks, Bayesian networks, graphical models, and graph neural networks work for integrating genomics, transcriptomics, proteomics, metabolomics, and other molecular data layers. It provides a practical framework for choosing network analysis methods based on your data types and research questions, with attention to quality controls, reproducibility, and interpretation limits.

The Case for Network-Based Multi-Omics Integration

Biological systems operate through interconnected molecular circuits instead of isolated components. Gene regulatory networks represent the interplay between chromatin, transcription factors, and genes that generates complex regulatory circuits controlling cellular identity [6]. When you measure only one molecular layer, you observe a partial view of these circuits. A transcriptomics experiment shows which genes are expressed, but it does not reveal the chromatin accessibility states or protein abundances that shape functional outcomes.

Network-based integration addresses this limitation by representing each omics layer as nodes and the relationships between them as edges. A node might represent a gene, a protein, a metabolite, or a clinical measurement. An edge might represent a correlation, a regulatory interaction, or a causal relationship inferred from data. The resulting structure captures modularity, redundancy, and cross-talk between molecular layers [14].

The practical value of this approach appears across research domains. In crop science, a single-cell multi-omics atlas of rice that simultaneously profiled chromatin accessibility and RNA expression in 116,564 cells from eight organs identified cell-type-specific gene regulatory networks and uncovered functions of regulatory hubs during development [5]. In clinical research, integrative analysis of transcriptomic, proteomic, and metabolomic profiles from colorectal cancer tissues revealed a significant interaction network comprising 22 lncRNAs, 14 mRNAs or proteins, and 9 metabolites, with one lncRNA emerging as a pivotal regulator [8]. In drug discovery, network-based methods support target identification, response prediction, and repurposing efforts [19].

Core Principles of Network Construction

Defining Nodes and Edges

The first decision in any network analysis is what constitutes a node and what constitutes an edge. Nodes are typically molecular features that pass quality filters and preprocessing steps. Edges represent relationships between those features, and the definition of an edge determines what biological question the network can answer.

Correlation networks define edges based on statistical association between feature measurements across samples. A Spearman correlation network integrating core metabolites, proteins, and renal function was used to characterize sepsis-associated acute kidney injury, highlighting five core metabolites with early temporal changes [7]. Correlation networks are computationally efficient and work with modest sample sizes, but they cannot distinguish direct from indirect relationships.

Bayesian networks define edges as probabilistic dependencies that can represent causal direction under specific assumptions. These networks require more samples and careful regularization because the search space of possible graph structures grows rapidly with the number of nodes.

Graphical models, including Gaussian graphical models, estimate partial correlations that represent conditional dependencies. An edge exists between two nodes only if their association persists after accounting for all other nodes in the network. This property makes graphical models useful for identifying direct regulatory relationships, but they require larger sample sizes and assume multivariate normality.

Data Modalities and Their Integration

The choice of network method depends on which omics layers you are integrating. Transcriptomics and chromatin accessibility data can be combined to infer gene regulatory networks that encompass transcription factor-gene interactions [6]. Proteomics and metabolomics data can be integrated to identify early metabolite alterations and construct diagnostic models [7]. Gut microbiota sequencing, metaproteomics, and host proteome data can be integrated to connect microbial macromolecular changes to host physiological outcomes [10].

Each data modality has distinct statistical properties. RNA sequencing produces count data with overdispersion. Proteomics produces intensity measurements with missing values from detection limits. Metabolomics produces peak intensities with batch effects. Chromatin accessibility produces sparse binary or count data. These properties affect which correlation measures, normalization methods, and network inference algorithms are appropriate.

Network Inference Methods

Network inference methods fall into several categories with different strengths and limitations. A systematic review of network-based multi-omics integration methods in drug discovery categorized approaches into four primary types: network propagation or diffusion, similarity-based approaches, graph neural networks, and network inference models [19].

Network propagation methods spread information through a known network structure, such as a protein-protein interaction network, to prioritize nodes relevant to a phenotype. These methods leverage prior knowledge but depend on the completeness and quality of the reference network.

Similarity-based approaches construct networks from pairwise similarity measures between samples or features. These methods are flexible and can integrate heterogeneous data types by computing separate similarity matrices for each omics layer and combining them.

Graph neural networks learn node representations by aggregating information from neighboring nodes. These methods can incorporate multiple prior knowledge sources and have shown strong performance in classification tasks [21]. Local augmented graph neural networks have been applied to cancer prognosis prediction [22]. Kolmogorov-Arnold network frameworks represent a newer development in this area [23].

Network inference models estimate graph structure directly from data. These include correlation networks, Bayesian networks, and graphical models. The choice among these depends on sample size, data distribution, and whether you need causal interpretation.

At a Glance: Method Selection Framework

Practical Workflow for Network-Based Integration

Step 1: Define the Biological Question and Data Requirements

Before collecting or analyzing data, specify the biological question in terms that determine method choice. A question about co-regulation of metabolites and proteins across disease states points toward correlation networks. A question about transcription factor targets in specific cell types points toward gene regulatory network inference from single-cell multi-omics data [6]. A question about drug response prediction points toward graph neural networks or network propagation methods [19].

Document the expected sample size, the number of features per omics layer, and the availability of independent validation data. These factors constrain which methods are feasible.

Step 2: Preprocess Each Omics Layer Independently

Apply quality control and normalization appropriate to each data type before integration. For RNA sequencing, this includes read alignment, gene-level quantification, and normalization for library size and composition. For proteomics, this includes peptide identification, protein rollup, and normalization for total protein or internal standards. For metabolomics, this includes peak detection, alignment, and batch correction.

Record all preprocessing parameters and software versions. Reproducibility depends on complete documentation of these choices.

Step 3: Select Features for Network Construction

Feature selection reduces the dimensionality of the integration problem. Common approaches include filtering by variance, selecting differentially abundant features, or using prior biological knowledge. In the colorectal cancer study, differential expression analysis identified 1,394 lncRNAs, 2,788 genes, 548 proteins, and 91 metabolites before network construction [8]. In the sepsis study, 13 differential renal metabolites and 112 differential renal proteins were identified before building the correlation network [7].

Feature selection criteria should be specified before analysis to avoid circular reasoning. If you select features based on differential abundance and then test whether network structure differs between conditions, the test is biased.

Step 4: Construct the Network

Apply the chosen network inference method to the selected features. For correlation networks, compute pairwise correlations and apply a threshold or use weighted network approaches. For graphical models, estimate the precision matrix with regularization. For Bayesian networks, search over graph structures using scoring criteria.

Validate network stability using bootstrap resampling or subsampling. Networks inferred from small samples can contain many spurious edges.

Step 5: Identify Network Modules and Key Nodes

Network modules are groups of densely connected nodes that often correspond to functional units. Weighted gene co-expression network analysis identifies modules correlated with phenotypic traits [15]. Module detection helps reduce the complexity of the network and focuses attention on biologically interpretable structures.

Hub nodes, which have high connectivity within a module, often represent regulatory centers. In the rice single-cell atlas, cell-type-specific regulatory hubs were identified through network analysis and their functions were validated experimentally [5].

Step 6: Integrate with Prior Knowledge and Validate

Compare the inferred network with known interactions from databases and literature. The human milk oligosaccharide biosynthesis study used a model aggregation approach that recovered known gene-enzyme relations and proposed candidates for uncharacterized reactions [18]. This type of validation increases confidence in novel predictions.

Independent experimental validation is the gold standard. In the colorectal cancer study, the predicted regulatory axis was validated through functional experiments showing that overexpression of the pivotal lncRNA restored expression of a tumor suppressor and increased levels of a signaling molecule [8].

Method Options and Tradeoffs

Correlation Networks

Correlation networks are the most accessible entry point for multi-omics integration. They require only a data matrix with features as rows and samples as columns. Spearman correlation is robust to outliers and monotonic relationships, making it a common choice for omics data [7].

The main limitation is that correlation does not imply direct interaction. Two metabolites may be correlated because they share a common upstream regulator, not because they interact directly. Correlation networks also assume that all samples come from a single population, which may not hold when integrating data from multiple conditions or batches.

Bayesian Networks

Bayesian networks represent conditional dependencies and can encode causal direction under assumptions about the data-generating process. They are well suited for integrating prior biological knowledge with observed data. The structure of a Bayesian network can be learned from data, specified from literature, or learned with prior constraints.

The computational cost of structure learning grows rapidly with the number of nodes. Practical applications typically restrict the node set to a few hundred features. Bayesian networks also require careful handling of continuous data, often through discretization or parametric assumptions.

Gaussian Graphical Models

Gaussian graphical models estimate the inverse covariance matrix, where zero entries indicate conditional independence. These models provide a rigorous framework for distinguishing direct from indirect relationships. Regularization methods such as graphical lasso make estimation feasible in high-dimensional settings.

The assumptions of multivariate normality and linear relationships limit applicability to some omics data types. Count data from RNA sequencing may require transformation or specialized models.

Graph Neural Networks

Graph neural networks learn to aggregate information across network structure and can integrate multiple omics layers with prior knowledge [21]. These methods have shown strong performance in classification and prognosis tasks [22]. The TEMINET approach uses intra-omics features to construct disease-specific networks, then applies graph attention networks and a multi-level framework to capture collective informativeness beyond pairwise relations [13].

Graph neural networks require large training samples and careful validation to avoid overfitting. Model interpretability remains a challenge, although attention mechanisms provide some insight into which nodes and edges drive predictions.

Multilayer Networks

Multilayer network approaches represent each omics layer as a separate network layer with inter-layer edges connecting related nodes across layers. This representation captures modularity, redundancy, and cross-talk between layers more faithfully than concatenation strategies [14]. Multilayer networks provide a mechanistic and interpretable scaffold for building digital twins of biological systems [14].

The complexity of multilayer networks increases the computational burden and the difficulty of visualization and interpretation. Standard network analysis tools may not support multilayer structures.

Records and Measurements for Network Analysis

Data Quality Records

Maintain a record of quality control metrics for each omics layer. For sequencing data, record read depth, alignment rates, and gene detection rates. For proteomics, record the number of identified proteins, missing value rates, and coefficient of variation for technical replicates. For metabolomics, record the number of detected features, batch effects, and internal standard performance.

These records support troubleshooting when network results are unstable or biologically implausible.

Analysis Documentation

Document every analysis step with software versions and parameters. Record the feature selection criteria, normalization methods, correlation measures, network inference algorithms, and threshold choices. This documentation enables reproducibility and supports method comparison.

The FAIR Guiding Principles provide a framework for making data findable, accessible, interoperable, and reusable [4]. Applying these principles to network analysis outputs, including the network files themselves, increases the value of the analysis for the research community.

Network Output Records

Save the network in a standard format that includes node attributes and edge weights. Record module assignments, hub node scores, and enrichment results. These outputs support downstream analysis and independent validation.

Common Failure Patterns in Network-Based Integration

Overinterpreting Correlation as Causation

The most common failure is treating correlation network edges as causal relationships. A correlation between a metabolite and a clinical outcome does not establish that the metabolite causes the outcome. The sepsis study used time series experiments to observe dynamic changes in core metabolites, providing stronger evidence than a static correlation network alone [7].

Ignoring Batch Effects and Technical Variation

Omics data collected across multiple batches contain technical variation that can dominate biological signal. If batch effects are not corrected before network construction, the resulting network may reflect technical artifacts instead of biological relationships. Record batch information and apply appropriate correction methods.

Using Too Few Samples

Network inference from small sample sizes produces unstable results. Edge presence and strength can change dramatically with the addition or removal of a few samples. Bootstrap resampling provides a quantitative assessment of edge stability.

Mixing Incompatible Data Types

Different omics layers have different measurement scales, noise structures, and missing data patterns. Simple concatenation of data matrices can obscure interactions between regulatory layers [14]. Use integration methods that account for the statistical properties of each data type.

Failing to Validate Predictions

Network analysis generates hypotheses, not conclusions. Predictions about regulatory relationships, biomarker candidates, or drug targets require independent validation. The rice study validated predicted regulatory hub functions experimentally [5]. The colorectal cancer study validated the predicted axis through functional experiments [8].

Quality Controls and Reproducibility

Pre-Registration of Analysis Plans

Specify the analysis plan before examining the data. This includes the feature selection criteria, network inference method, threshold choices, and validation strategy. Pre-registration reduces the risk of overfitting and selective reporting.

Benchmarking Against Known Interactions

Compare inferred networks with known interactions from curated databases. The human milk oligosaccharide study recovered known gene-enzyme relations and used this recovery rate as a validation metric [18]. Benchmarking provides a quantitative measure of network quality.

Sensitivity Analysis

Test how network results change with different preprocessing choices, correlation measures, and thresholds. A robust network should show consistent module structure and hub nodes across reasonable parameter choices.

Independent Replication

Replicate the analysis in an independent cohort or experimental system. The sepsis study validated metabolite biomarkers in a clinical cohort after initial discovery in a mouse model [7]. Replication provides the strongest evidence that network findings generalize.

Welfare and Safety Context for Biological Research

Data Sharing and Privacy

Genomic and clinical data carry privacy obligations. The NIH Genomic Data Sharing Policy establishes expectations for responsible sharing of genomic data from NIH-funded research [3]. Researchers should review applicable policies before depositing or sharing omics data.

Data Resources and Standards

Public data resources support method development and validation. The European Bioinformatics Institute provides training and data resources for bioinformatics [1]. The National Center for Biotechnology Information maintains databases for sequence, expression, and other molecular data [2]. Using standardized data formats and public repositories increases the value of network analyses.

Responsible Interpretation

Network analysis results can have implications for disease risk, prognosis, or treatment response. Interpret results with appropriate caution and avoid overstating clinical relevance. The stroke review emphasized that single-biomarker and single-omics approaches fail to resolve biological heterogeneity, but also noted translational barriers including analytical standardization and regulatory readiness [17].

Professional Escalation Criteria

When to Seek Additional Expertise

Escalate to a bioinformatics specialist or statistician when any of the following conditions apply:

• Sample size is small relative to the number of features, and you are unsure whether the chosen network method is appropriate
• Data types have complex statistical properties that violate method assumptions
• Network results are unstable across reasonable parameter choices
• You need to integrate more than three omics layers with different data structures
• The research question requires causal interpretation that correlation networks cannot support

When to Reconsider the Analysis Approach

Reconsider the analysis approach when:

• The network contains an implausibly large number of edges with high weights
• Module structure does not align with known biological pathways
• Hub nodes are predominantly technical artifacts such as ribosomal proteins or batch-associated genes
• Validation against known interactions shows poor recovery rates
• Independent replication fails to reproduce key network features

Frequently Asked Questions

What is the difference between a correlation network and a graphical model?

A correlation network draws an edge between two features when their pairwise correlation exceeds a threshold. A graphical model draws an edge only when two features are conditionally dependent after accounting for all other features in the network. Graphical models therefore produce sparser networks that are more likely to represent direct relationships, but they require larger sample sizes and stronger distributional assumptions.

How many samples do I need for network-based multi-omics integration?

The required sample size depends on the method and the number of features. Correlation networks can work with dozens of samples when the feature set is restricted to a few hundred. Gaussian graphical models and Bayesian networks typically require hundreds of samples for stable estimation. Graph neural networks require even larger training sets and independent validation data. Assess stability through bootstrap resampling instead of relying on a fixed sample size threshold.

Can I integrate data from public repositories with my own measurements?

Yes, but you must account for batch effects and differences in data generation protocols. Public data resources such as those maintained by the European Bioinformatics Institute and the National Center for Biotechnology Information provide access to diverse omics datasets [1][2]. Before integrating public and local data, verify that the measurement platforms, sample types, and preprocessing methods are compatible.

How do I validate a network inferred from my data?

Validate the network by comparing it with known interactions from curated databases, testing the stability of edges through bootstrap resampling, and performing sensitivity analysis across parameter choices. The strongest validation is independent experimental confirmation of predicted relationships, as demonstrated in studies that functionally validated regulatory hubs and axes [5][8].

What are the main limitations of network-based multi-omics integration?

The main limitations include computational scalability for large feature sets, difficulty of biological interpretation for complex models, and the challenge of establishing standardized evaluation frameworks [19]. Correlation networks cannot distinguish direct from indirect relationships. Bayesian networks require strong assumptions for causal interpretation. Graph neural networks require large samples and careful validation.

How do I choose between a graph neural network and a traditional network inference method?

Choose a graph neural network when you have a large labeled dataset, a prediction task such as diagnosis or prognosis, and the need to integrate multiple omics layers with prior knowledge [21][22]. Choose a traditional network inference method when your primary goal is understanding biological relationships, your sample size is limited, or you need interpretable network structure.

What is a multilayer network and when should I use one?

A multilayer network represents each omics layer as a separate network with inter-layer edges connecting related nodes across layers. This approach captures cross-talk between regulatory layers more faithfully than concatenation strategies [14]. Use multilayer networks when you need to represent interactions between different molecular scales and when interpretability of the cross-layer structure is important.

How do I report network analysis results for publication?

Report the preprocessing steps for each omics layer, the feature selection criteria, the network inference method with all parameters, the validation strategy, and the stability assessment. Provide the network in a standard format as supplementary data. Follow the FAIR Guiding Principles to make the data findable, accessible, interoperable, and reusable [4].

Related Bioinformatics Guides

• Bayesian Networks in Systems Biology: Probabilistic Graph Models for Veterinary and Biological Inference
• Multi-Omics Integration Strategies
• Hidden Markov Models in Biological Sequence Analysis
• Normal Mode Analysis and Elastic Network Models for Protein Flexibility
• Data Sharing and Privacy in Genomic Research

References and Further Reading

• EMBL-EBI Training. European Bioinformatics Institute.
• NCBI Data Resources. National Center for Biotechnology Information.
• Genomic Data Sharing Policy. National Institutes of Health.
• The FAIR Guiding Principles. Scientific Data.
• A single-cell multi-omics atlas of rice.. Nature, 2025.
• Gene regulatory network inference in the era of single-cell multi-omics.. Nature reviews. Genetics, 2023.
• Metabolomics- and proteomics-based multi-omics integration reveals early metabolite alterations in sepsis-associated acute kidney injury.. BMC medicine, 2025.
• Integrative multi-omics analysis reveals the LncRNA 60967.1-PLCD4-ATRA axis as a key regulator of colorectal cancer progression and immune response.. Molecular cancer, 2025.
• Multi-omics and network pharmacology approaches reveal Gui-Ling-Ji alleviates oligoasthenoteratozoospermia by regulating arachidonic acid pathway.. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2024.
• Integrative multi-omics analysis of autism spectrum disorder reveals unique microbial macromolecules interactions.. Journal of advanced research, 2025.
• Huiyang Shengji decoction promotes healing of diabetic skin ulcers via the NF-κB/STAT3/NLRP3 signaling pathway: A multi-omics analysis.. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2025.
• Multi-omics network toxicology reveals the role of benzo[a]pyrene in ovarian cancer: Integrating gut microbiota dynamics and Mendelian randomization.. Ecotoxicology and environmental safety, 2025.
• TEMINET: A Co-Informative and Trustworthy Multi-Omics Integration Network for Diagnostic Prediction.. 2024.
• Multilayer network approaches to omics data integration in digital twins for cancer research.. 2026.
• Multi-omics integration of gut-skin axis in probiotic-treated dermatological conditions.. 2026.
• Multi-omics dissection of metabolic pathways for differential flavonoid accumulation in Solanum pennellii and S. lycopersicum.. 2026.
• Multi-Omics Integration in Stroke: Neuroinflammatory Endotypes, Immune Cell Crosstalk, and Precision Biomarker Discovery.. 2026.
• Elucidating Human Milk Oligosaccharide biosynthetic genes through network-based multi-omics integration. Nature Communications, 2022.
• Network-based multi-omics integrative analysis methods in drug discovery: a systematic review. BioData Mining, 2025.
• Network-based multi-omics integration reveals metabolic risk profile within treated HIV-infection. 2022.
• Graph Neural Networks with Multiple Prior Knowledge for Multi-Omics Data Analysis. IEEE Journal of Biomedical and Health Informatics, 2023.
• Local augmented graph neural network for multi-omics cancer prognosis prediction and analysis. Methods, 2023.
• MOKAN: A Multi-Omics Data Analysis Framework Using Kolmogorov-Arnold Networks. IEEE Journal of Biomedical and Health Informatics, 2026.
• Computational approaches for network-based integrative multi-omics analysis. Frontiers in Molecular Biosciences, 2022.

This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.